Bangalore: Biocon Ltd has displayed the outcomes of phase-I studies on its oral insulin product, IN-105, at the European Association for Study of Diabetes conference held in Amsterdam on Friday.
Esteemed India:: India Media Hub:: Indian Rummy:: Latest News:: Mid-Cap Stocks:: Sports Bazaar
Bangalore: Biocon Ltd has displayed the outcomes of phase-I studies on its oral insulin product, IN-105, at the European Association for Study of Diabetes conference held in Amsterdam on Friday. 
